p-Akt was also suggested as prognostic biomarker for patients with melanoma, whose increased expression was significantly related with melanoma invasion and a poorer 5-year patient survival in a clinicopathologic study of 292 cases: normal nevi, dysplastic nevi, primary melanomas, and metastatic melanomas64. This evidence concerns the gene AKT1 and melanoma.